Discuss Market Access challenges with european payer network

Payer budgets are under pressure and payers are becoming increasingly critical when assessing new health technologies. Payer input and validation on important Market Access topics and strategies is vital for success. We can mobilize our European payer network (open PDF) * via interviews, surveys or advisory boards to help you get external validation early and efficiently. *Our payer network covers national and regional (ex-) payers, proxy-to-payers, hospital payers and health economics experts.

A payer network to discuss pricing and reimbursement topics

We are a boutique strategy consulting firm advising life sciences companies throughout Europe since 2000. By engaging with our European payer network, you will have the unique opportunity to receive advice on how to deal with your challenges in Market Access, pricing (of innovative therapies) and reimbursement. With our proven approach we will deliver the first results within 4 weeks.

We help you find the answers to a wide variety of Market Access questions:

  • What is the most optimal pricing and reimbursement strategy for a new product?
  • How to translate clinical and economic outcomes into an attractive payer value story?
  • How can payers and pharma work together on innovative pricing models?
  • What are the characteristics of the preferred pricing agreement?

How to connect with our payer network?

Do you want to explore the possibilities to connect with our European payer network? Sign up for a 45-minute exploratory intake with Europe’s foremost health economics expert, Lieven Annemans and Vintura’s pharma expert, Bas Amesz.

exploratory discussion with prof. Lieven Annemans and Bas Amesz

  • This field is for validation purposes and should be left unchanged.
All Cases
Check it out now
All Articles
Find out more